Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort
- 13 January 2016
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 36 (5) , 697-702
Abstract
The objective of this study is to describe the characteristics of patients with Erasmus syndrome (ES) in a large SSc Brazilian cohort. Nine hundred and forty-seven SSc patients attended at the Scleroderma Outpatient Clinic at two academic medical centers in Brazil and classified as SSc according to the ACR/EULAR criteria were retrospectively studied. Information on demographics, clinical, and laboratory features was obtained by chart review. ES patients had their HLA class II characterized by PCR-SSO method as available. Among the 947 SSc patients studied, nine (0.9 %) had ES. These ES patients were predominantly male (78 %) and smokers (68 %) and presented diffuse SSc (67 %). Mean time of occupational exposure to silica was 13.7 years, with mean age at onset of 47 years. Previous history of tuberculosis was referred by 33 % of the ES patients. All the ES patients presented Raynaud’s phenomenon, esophageal involvement, and interstitial lung disease (ILD). Antinuclear antibodies were present in all the ES patients, while anti-topoisomerase I was positive in 44 % and no patient had anticentromere antibody. Three different HLA-DQB alleles (0506, 0305, and 0303) were observed. Compared to non-ES cases, patients with ES were associated with male gender (p < 0.001), diffuse SSc (p < 0.05), ILD (p < 0.05), positive anti-topoisomerase I antibodies (p < 0.05), and death (p < 0.05). Multivariate analysis did not confirm that silicosis is an independent risk factor for SSc. To conclude, ES was rare in this large SSc cohort, although associated with a bad prognosis.Keywords
This publication has 29 references indexed in Scilit:
- Association of occupational exposure with features of systemic sclerosisJournal of the American Academy of Dermatology, 2015
- HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian PatientsDisease Markers, 2013
- Prevalence of connective tissue disease in silicosis (1985–2006)—a report from the state of michigan surveillance system for silicosisAmerican Journal of Industrial Medicine, 2010
- Geoepidemiology of systemic sclerosisAutoimmunity Reviews, 2010
- Male systemic sclerosis and occupational silica exposure—a population‐based studyAustralian and New Zealand Journal of Medicine, 2000
- Connective tissue disease and silicosisAmerican Journal of Industrial Medicine, 1999
- Anti—topoisomerase i antibodies in silica‐associated systemic sclerosis. A model for autoimmunityArthritis & Rheumatism, 1994
- Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.1993
- Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosisBritish Journal of Dermatology, 1990
- Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations.1957